Apart from answering the concerns of others I really liked this part of his reply,
"Also in Australia we expect to get approval for CVac before the US and EU phase III study is complete. This is because in Australia CVac is categorised as a category 3 blood product, very much like the UAE."
Good luck to all long term holders
- Forums
- ASX - By Stock
- IMM
- reply from martin rogers re dubai release
reply from martin rogers re dubai release, page-2
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
39.5¢ |
Change
0.005(1.28%) |
Mkt cap ! $573.7M |
Open | High | Low | Value | Volume |
38.5¢ | 40.0¢ | 38.5¢ | $1.022M | 2.599M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17394 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 60247 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17394 | 0.390 |
6 | 90082 | 0.385 |
9 | 81777 | 0.380 |
2 | 33070 | 0.375 |
5 | 111756 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 60247 | 1 |
0.400 | 43444 | 4 |
0.405 | 183170 | 3 |
0.410 | 238354 | 9 |
0.415 | 211366 | 9 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |